Development of a vaccine construct against <i>Pneumocystis jirovecii</i> pneumonia using computational tools

<i>Pneumocystis jirovecii</i> poses a significant threat to immunocompromised individuals, necessitating the development of an effective vaccine. This study employs an immunoinformatics approach to design a promising vaccine candidate against <i>P. jirovecii</i>. Utilizing various computational tools, the study identified potential antigenic epitopes capable of eliciting immune responses within the <i>P. jirovecii</i> major surface glycoprotein C. The chosen epitopes were evaluated using computational tools for their allergenicity, interferon-γ and interleukin activation ability, and toxicity, ensuring the selection of immunogenic and safe candidates. These analyses led to the selection of 10 epitopes, which were then linked with adjuvants to model a potential vaccine candidate. Molecular docking and molecular dynamics simulations were performed in a solvent environment to investigate the binding interactions between the vaccine candidate and toll-like receptors, along with calculations of thermodynamic properties. Finally, <i>in silico</i> immune simulations were performed to analyze the immunogenic potential of the vaccine candidate. Future prospects include <i>in vitro</i> and <i>in vivo</i> validation of the vaccine candidate and the exploration of novel adjuvants to enhance its immunogenicity. This study contributes to the ongoing efforts to develop a preventive solution against <i>P. jirovecii</i> infections, addressing a critical gap in the protection of immunocompromised individuals.